Search Login Register

Flecainide (Tambocor) Summary

Description: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial arrhythmias and tachycardias. Paradoxically, however, in myocardial infarct patients with either symptomatic or asymptomatic arrhythmia, flecainide exacerbates the arrhythmia and is not recommended for use in these patients.

Also Known As: Tambocor; R818; 3M Brand of Flecainide Acetate; Alphapharm Brand of Flecainide Acetate; Alpharma Brand of Flecainide Acetate Show All >>

Networked: 910 relevant articles (149 outcomes, 154 trials/studies) for this Drug

Key Diseases for which Flecainide is Relevant

  1. Atrial Fibrillation : 46 outcomes 41 studies in 205 results
  2. Tachycardia (Tachyarrhythmias) : 28 outcomes 11 studies in 191 results
  3. Supraventricular Tachycardia : 23 outcomes 11 studies in 93 results
  4. Ventricular Tachycardia : 16 outcomes 10 studies in 115 results
  5. Cardiac Arrhythmias (Arrythmia) : 15 outcomes 43 studies in 175 results
Show All >>

Drugs Related to Flecainide

  1. Propafenone (Rythmol)
  2. Amiodarone (Amiodarona)
  3. Encainide
  4. Mexiletine (Mexitil)
  5. Quinidine (Chinidin)
  6. Sotalol (Sotalol Hydrochloride)
  7. Digoxin (Digitek)
  8. Lidocaine (Xylocaine)
  9. Flecainide (Tambocor)
  10. cifenline (cibenzoline)
Show All >>

Therapies Related to Flecainide

  1. Electric Countershock (Cardioversion)
  2. Drug Therapy (Chemotherapy)
  3. Oral Administration
  4. Intensive Care (Surgical Intensive Care)
  5. Intravenous Infusions
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.